Aileron Therapeutics Revenue and Competitors

Watertown Town, MA USA

Location

$218.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aileron Therapeutics's estimated annual revenue is currently $3.3M per year.(i)
  • Aileron Therapeutics's estimated revenue per employee is $232,500
  • Aileron Therapeutics's total funding is $218.2M.

Employee Data

  • Aileron Therapeutics has 14 Employees.(i)
  • Aileron Therapeutics grew their employee count by -53% last year.

Aileron Therapeutics's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
COO and PresidentReveal Email/Phone
3
SVP ResearchReveal Email/Phone
4
AnalystReveal Email/Phone
5
President and CEOReveal Email/Phone
6
Corporate ControllerReveal Email/Phone
7
Interim CFOReveal Email/Phone
8
AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Aileron Therapeutics?

Aileron Therapeutics is an emerging biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeutics for the treatment of cancer and other diseases. Aileron's technology is the first and only process that allows peptides to penetrate cells in a sequence-independent manner. Aileron is developing the first generation of peptide therapeutics directed at intra-cellular protein-protein interaction targets that are not addressable by small molecule or biological drugs.

keywords:N/A

$218.2M

Total Funding

14

Number of Employees

$3.3M

Revenue (est)

-53%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aileron Therapeutics News

2022-04-20 - Hypoxia Market Research Report, Business Growth ...

... Segments, Future Trends and Forecast 2028 | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Aileron Therapeutics.

2022-04-20 - Hypoxia Market Research Report, Business Growth ...

... Segments, Future Trends and Forecast 2028 | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Aileron Therapeutics.

2022-04-17 - Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN ...

As a group, equities research analysts forecast that Aileron Therapeutics will post -0.33 EPS for the current fiscal year.

2022-04-17 - Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN ...

A number of analysts recently weighed in on the stock. William Blair reaffirmed an “outperform” rating on shares of Aileron Therapeutics in a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M323%N/A
#2
$15.8M6331%N/A
#3
$19.8M68-9%N/A
#4
$6.9M756%N/A
#5
$9.3M936%N/A